# OnCo record rash-skin-toxicity (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/rash-skin-toxicity/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "rash-skin-toxicity" ;
  schema:name "Rash and skin toxicity (acneiform rash, paronychia)"@en ;
  schema:alternateName "rash"@en, "skin rash"@en, "skin toxicity"@en, "skin toxicities"@en, "dermatological toxicity"@en, "dermatologic toxicity"@en, "cutaneous toxicity"@en, "acneiform rash"@en, "acneiform"@en, "papulopustular rash"@en, "EGFR rash"@en, "paronychia"@en, "nail changes"@en, "xerosis"@en, "dry skin"@en, "photosensitivity"@en, "maculopapular rash"@en, "Stevens-Johnson"@en, "SJS"@en, "vitiligo"@en, "hyperpigmentation"@en ;
  schema:description "Skin reactions from cancer drugs, ranging from the acne-like rash that nearly everyone on an EGFR inhibitor gets (a sign the drug is working) to painful nail-fold infections, itching, and rare severe blistering reactions."@en ;
  schema:url <https://onco.cc/terms/rash-skin-toxicity/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Drug_eruption> ;
  schema:citation <https://en.wikipedia.org/wiki/Drug_eruption>, <https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/cetuximab>, <https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/panitumumab> ;
  onco:related <https://onco.cc/terms/hand-foot-syndrome/>, <https://onco.cc/terms/irae/>, <https://onco.cc/terms/dose-modification/>, <https://onco.cc/terms/tki-term/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/> ;
  onco:drugs <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/osimertinib/>, <https://onco.cc/drugs/enfortumab-vedotin/> .